TrialInvestigational new drugs2021

Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.

Yoichiro Aoshima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.